BRTX Financials 07/16/2014 05:23:47 BioRestorativ

BRTX Financials 07/16/2014 05:23:47
BioRestorative Therapies, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 2 16 - -
Cost of Revenue - 1 - -
Gross Profit 1 14 - -
Operating Expenses
Research and Development 1,594 757 12 12
Sales, General and Admin. 3,160 4,830 3,540 2,058
Non-Recurring Items - - - -
Other - - - -
Operating Income (4,752) (5,572) (3,552) (2,069)
Income From Continuing Operations
Add'l Income/Expense Items (628) (372) (262) (170)
Earnings Before Interest and Tax (5,373) (5,875) (3,814) (2,240)
Interest Expense 371 592 260 24
Earnings Before Tax (5,744) (6,467) (4,074) (2,264)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (5,751) (6,537) (4,074) (2,264)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (5,751) (6,537) (4,074) (2,264)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (5,751) (6,537) (4,074) (2,264)